Topical blood stopper agents during adenoid surgery in young children; a prospective randomized controlled trial.

Topical blood stopper agents during adenoid surgery in young children; a prospective randomized controlled trial.

Eur Arch Otorhinolaryngol. 2018 Mar 10;:

Authors: Abdallah RA, Ragab SM, Hassanin MZ

Abstract
OBJECTIVE: To investigate the safety and efficacy of two topical blood stopper modulators; Ankaferd blood stopper (ABS) and feracrylum 1% solution (FS) during adenoid surgery.
STUDY DESIGN: Prospective randomized trial.
METHODS: Two hundred and twenty five consecutive pediatric adenoid patients aged from 9 months to 2 years old were studied. Patients were randomly allocated into two haemostatic groups; (ABS, FS) and normal saline (control group).
RESULTS: ABS and FS groups showed a significantly less intra operative blood loss (16.4 ± 2.6/22 ± 6.2), operative time (9.31 ± 1.9/11.2 ± 1.6 min), use of cautery (10.6/25.3%), postoperative analgesics (3 ± 1.1/3.8 ± 1.2), duration to return normal diet (2.4 ± 1.2/3.9 ± 0.9) and operating theatre cost (233 ± 48$ and 279 ± 40$) than the control group.
CONCLUSION: AFS and FS are easy, safe, and reliable topical haemostatic modulators that could be used in adenoid surgery.

PMID: 29525823 [PubMed - as supplied by publisher]

from #ENT-PubMed via ola Kala on Inoreader http://ift.tt/2FuVdEx